Coffee and Cardiovascular Health: Heart Disease, Arrhythmia, and Longevity

Table of Contents

  1. Overview
  2. Coffee and All-Cause Mortality
  3. Coronary Heart Disease and Stroke
  4. Arrhythmia and Atrial Fibrillation
  5. Cholesterol and the Brewing Method Effect
  6. Blood Pressure
  7. Proposed Cardioprotective Mechanisms
  8. Practical Guidance
  9. Sources
  10. Featured Videos

Overview

For decades, coffee was viewed with suspicion by cardiologists, largely because of its ability to acutely raise heart rate and blood pressure and because unfiltered coffee was shown to raise LDL cholesterol. Modern cardiovascular epidemiology has overturned that view. Large prospective cohort studies and umbrella reviews now consistently show that moderate coffee consumption is associated with a lower risk of cardiovascular disease, stroke, heart failure, and all-cause mortality. The protective pattern holds across both caffeinated and decaffeinated coffee and in populations with established cardiovascular disease.

Coffee and All-Cause Mortality

The most influential studies on coffee and mortality include Freedman and colleagues' 2012 NIH-AARP Diet and Health Study of over 400,000 adults, which found that men drinking six or more cups per day had about a 10 percent lower risk of death from all causes, and women had a 15 percent reduction, compared with non-drinkers. The protective association was strongest for death from heart disease, stroke, diabetes, and infections.

Ding and colleagues' 2015 analysis pooling three large Harvard cohorts (Nurses' Health Study, NHS II, and Health Professionals Follow-up Study) confirmed that three to five cups per day was associated with the lowest mortality. A 2017 umbrella review by Poole and colleagues in the BMJ, synthesizing 201 meta-analyses across hundreds of outcomes, concluded that the "sweet spot" for mortality reduction is three to four cups per day, with roughly a 17 percent lower risk of all-cause mortality at that intake.

A 2017 multiethnic cohort analysis by Park and colleagues in Annals of Internal Medicine confirmed that the mortality benefit holds across African American, Native Hawaiian, Japanese American, Latino, and white populations—strong evidence against the idea that the association is confined to one demographic.

Coronary Heart Disease and Stroke

The 2014 meta-analysis by Ding and colleagues in Circulation, pooling 36 prospective studies, found a U-shaped relationship between coffee and coronary heart disease risk, with the lowest risk at three to five cups per day (about 15 percent lower than non-drinkers). Intakes above six cups per day showed no additional benefit but also no significant harm in most populations.

For stroke, the pattern is similar. A 2011 meta-analysis by Larsson and Orsini found that two to four cups per day was associated with roughly a 14 percent reduction in stroke risk. The benefit was present for both ischemic and hemorrhagic stroke, though the effect size was smaller for the latter.

Arrhythmia and Atrial Fibrillation

A long-standing concern has been whether caffeine triggers atrial fibrillation (AF) or other arrhythmias. The evidence from modern cohort studies actually suggests the opposite: regular coffee consumption is associated with a lower, not higher, risk of AF. A 2018 meta-analysis by Cheng and colleagues pooled 11 studies and found no increased risk of AF at moderate intakes, and a trend toward reduced risk at three or more cups per day.

A 2022 study from the UK Biobank by Kistler and colleagues, following over 380,000 participants for more than a decade, found that drinking two to three cups of coffee per day was associated with a significantly lower incidence of AF, supraventricular tachycardia, and total cardiovascular disease. The authors suggested that long-standing clinical advice to avoid coffee for palpitations may not be justified by the data.

Cholesterol and the Brewing Method Effect

One genuine concern is the effect of unfiltered coffee on LDL cholesterol. The diterpenes cafestol and kahweol—the same compounds that contribute to anti-cancer effects—raise serum LDL by inhibiting hepatic LDL receptor activity. French press, Turkish, and Scandinavian boiled coffee retain the highest levels of these compounds and can raise LDL by 5 to 10 mg/dL at moderate intakes over several weeks.

Paper filtration removes nearly all cafestol and kahweol, which is why drip coffee does not raise LDL. Tverdal and colleagues' 2020 analysis of over 500,000 Norwegian adults found that filtered coffee was associated with lower cardiovascular mortality than unfiltered coffee, consistent with this mechanism. For individuals with dyslipidemia or existing cardiovascular disease, filtered coffee is the safer choice.

Blood Pressure

Acute caffeine intake raises blood pressure by roughly 5 to 10 mm Hg systolic in non-habitual drinkers, but this effect diminishes within a few weeks of regular consumption as tolerance develops. In long-term cohort studies, regular coffee drinkers do not show higher rates of hypertension than non-drinkers, and some analyses suggest a modest protective effect. The American Heart Association does not advise abstention from coffee for hypertension, though patients with very elevated or uncontrolled blood pressure should discuss their caffeine intake with their physician.

Proposed Cardioprotective Mechanisms

Practical Guidance

Sources

Video Thumbnail

2022 Research: How Daily Coffee Benefits Your Heart — My Longevity Experiment

Video Thumbnail

Association of Coffee Consumption with All-Cause and CVD Mortality — Mayo Proceedings

Video Thumbnail

Study: Drinking Black Coffee Could Increase Longevity — Fox News

Back to Table of Contents